00495nas a2200181   4500000000100000000000100001008004100002100001400043700001300057700001300070700001500083700002100098700001400119245014700133300001200280490000700292022001400299       2012                            d1 aC. Morgan1 aC. Poole1 aM. Evans1 aA. Barnett1 aS. Jenkins-Jones1 aC. Currie00aWhat next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes  a4605-120 v97  a0021-972x